Brief: Allena Pharmaceuticals Reports Q2 Loss Per Share $0.54

Allena Pharmaceuticals

07/08/2019 13:12

Aug 7 (Reuters) - Allena Pharmaceuticals Inc  ALNA.O :
    * ALLENA PHARMACEUTICALS REPORTS SECOND QUARTER 2019
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * Q2 LOSS PER SHARE $0.54
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.54 -- REFINITIV IBES
DATA
    * TOPLINE DATA FROM PHASE 3 URIROX-1 TRIAL AND STUDY 206 ON
TRACK
FOR SECOND HALF OF 2019
    * ALLENA PHARMACEUTICALS - EXPECTS  EXISTING CASH & CASH
EQUIVALENTS WILL BE SUFFICIENT TO FUND ITS OPERATING EXPENSES &
CAP EX REQUIREMENTS INTO Q4 OF 2020
    * AS OF JUNE 30, 2019, CASH AND CASH EQUIVALENTS WERE $48.5
MILLION, AS COMPARED TO $61.6 MILLION AS OF DECEMBER 31, 2018

Source text for Eikon:  ID:nGNX1XRm09 
Further company coverage:  ALNA.O 

 ((Reuters.Briefs@thomsonreuters.com;))